Ivacaftor for cystic fibrosis

被引：4
|
作者：
Barry, Peter J. [1 ,2 ]
Donaldson, Anna L. [3 ,4 ]
Jones, Andrew M. [1 ,2 ]
机构：
[1] Manchester Univ Hosp NHS Fdn Trust, Wythenshawe Hosp, Manchester Adult Cyst Fibrosis Ctr, Manchester M23 9LT, Lancs, England
[2] Univ Manchester, Fac Biol Med & Hlth, Div Infect Immun & Resp Med, Manchester, Lancs, England
[3] Hlth Educ North West, Regatta Pl,Brunswick Business Pk, Liverpool L3 4BL, Merseyside, England
[4] Univ Liverpool, Farr Inst, Dept Publ Hlth & Policy, Liverpool L69 3GL, Merseyside, England
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2018年 / 361卷
关键词：
RANDOMIZED CONTROLLED-TRIAL; G551D MUTATION; TEZACAFTOR-IVACAFTOR; EFFICACY; SAFETY; POTENTIATOR;
D O I：
10.1136/bmj.k1783
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：7
相关论文
共 50 条
  • [1] Ivacaftor for patients with cystic fibrosis
    Wainwright, Claire E.
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2014, 8 (05) : 533 - 538
  • [2] Ivacaftor approved for cystic fibrosis
    Traynor, Kate
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2012, 69 (05) : 363 - 363
  • [3] Ivacaftor therapy for cystic fibrosis
    McColley, Susanna A.
    [J]. EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (11): : 1225 - 1232
  • [4] Ivacaftor (Kalydeco) for Cystic Fibrosis
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2012, 54 (1388): : 29 - 30
  • [5] Lumacaftor/Ivacaftor (Orkambi) for Cystic Fibrosis
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1491): : 41 - 42
  • [6] Safety of ivacaftor in children with cystic fibrosis
    不详
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2016, 77 (03) : 129 - 129
  • [7] Lumacaftor/Ivacaftor: A Review in Cystic Fibrosis
    Deeks, Emma D.
    [J]. DRUGS, 2016, 76 (12) : 1191 - 1201
  • [8] Ivacaftor Imaging Response in Cystic Fibrosis
    Hoare, Siobhan
    McEvoy, Sinead
    McCarthy, Colin J.
    Kilcoyne, Aoife
    Brady, Darragh
    Gibney, Brian
    Gallagher, Charles G.
    McKone, Edward F.
    Dodd, Jonathan D.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189 (04) : 484 - 484
  • [9] Tezacaftor and ivacaftor for the treatment of cystic fibrosis
    Paterson, Sarah L.
    Barry, Peter J.
    Horsley, Alexander R.
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2020, 14 (01) : 15 - 30
  • [10] Lumacaftor/Ivacaftor: A Review in Cystic Fibrosis
    Emma D. Deeks
    [J]. Drugs, 2016, 76 : 1191 - 1201
12345